Scienza e Tecnologia
AMSilk Announces Extension of Series C Financing to EUR 54M
Proceeds from the financing will enable AMSilk to accelerate the ongoing scale-up of its industrialization and commercialization projects worldwide, to meet the ever-increasing demand for AMSilk's innovative materials.
AMSilk's unique bio-fabrication reprograms microorganisms to enable them to produce silk proteins into usable forms such as powders, hydrogels, fibers, and coatings. Coupled with its unique fermentation process, this allows the Company to produce complex proteins in large quantities for various market segments including textiles, medical use or consumer goods. AMSilk's bio-fabricated silk materials are 100% protein, fully biodegradable and do not include any source of micro plastics.
:
,
:
Since the successful EUR 29 million financing in 2021, the Company has invested in partnership agreements with world-leading brands in the apparel, medical and automotive industry, and supply contracts with leaders from the biotech industry.
AMSilk GmbH is the world's first industrial supplier of innovative bio-fabricated plant based raw materials that are fully biodegradable at industrial quantities, and has its headquarters in Neuried/ Munich, Germany . Using a patented biotechnological process, AMSilk's smart-performance biotech material based on silk proteins can be converted into usable forms such as powders, hydrogels, fibers, and coatings. AMSilk's bio-fabricated silk is made from plant-based renewable raw materials that are 100% protein, and does not involve any natural farming processes. The bio-fabricated materials are fully biodegradable under aerobic and marine conditions, and as they do not include any source of micro plastics there is no microplastic wash out during the product life.
Discover more at www.amsilk.com.
View original content:https://www.prnewswire.co.uk/news-releases/amsilk-announces-extension-of-series-c-financing-to-eur-54m-301789096.html